Drug Manufacturers - Specialty & Generic | Healthcare
Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal health, biotech, crop protection, and specialty chemicals companies in India, the United States, Canada, Europe, South East Asia, and internationally. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredients (APIs). Its Crop Protection segment manufactures pesticides and herbicides, which include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. The company also collaborates with other companies; and offers solutions in contract research, custom synthesis, and custom manufacturing of intermediates and active ingredients. In addition, it offers human health products, such as anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, hemorheologic, anti-diabetic, anti-thrombotic, anti-hypertensive, anti-inflammation, and analgesic; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company also exports its products. The company was formerly known as Hikal Chemical Industries Ltd. and changed its name to Hikal Limited in April 2000. Hikal Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.
Market Cap
46792728576
Current Price
379.5
52 Week Range
294.3 - 464.75
Previous Close
376.85
Open
377.8
Sector
Healthcare
Address
Great Eastern Chambers, 6th Floor Sector 11 C.B.D. Belapur, Navi Mumbai, 400614, India
Phone
+91-22627-70299
Website
https://www.hikal.com
Day Low
377.5
Day High
378.8
Dividend Yield
0.32
PE Ratio
51.35318
Earnings Per Share
7.39
Beta
0.634
EBITDA
3334000128
Book Value
102.342
EPS
11.3
Name | Title | Age | Year Born |
---|---|---|---|
Mr. Jai Vishwanath Hiremath | Founder & Executive Chairman | 76 | 1948 |
Mr. Sameer Jai Hiremath | MD & Vice Chairman | 50 | 1974 |
Mr. Rajasekhar Reddy Chintakindi | Company Secretary & Compliance Officer | - | - |
Mr. Anish Dilip Swadi | Senior President of Animal Health & Business Transformation | - | - |
Mr. Kuldeep Jain | Chief Financial Officer | - | - |
Mr. Ratish Jha | President of Human Resources | - | - |
Mr. Manoj Mehrotra | President of Pharmaceuticals Business | 62 | 1962 |
Dr. T. Devanathan | Head of IP & Quality, Pharmaceuticals | - | - |
Mr. Vimal Deep Kulshrestha | President of Crop Protection | 59 | 1965 |
Mansukh Gokalbhai Patel | Head of Sustainability & Corporate EHS | - | - |
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.